- Two Cases Reports of Prevention of Hypoglycemia with Administration of Insulin lispro on Diabetes in Pregnancy
-
Park UH, Lee JE, Koh SH, Im SB, Lee JR, Lee JY, Hwang SO, Im MW, Lee WY
- KMID: 2076653
- Korean J Obstet Gynecol.
- 2002 Jul;45(7):1209-1213.
Insulin therapy is indicated in the treatment of gestational diabetic women and overt diabetic pregnant women for hyperglycemia after failure to respond to the diets and exercise regimens. The insulin... -
- CITED
-
- Close
- SHARE
-
- Close
- Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus
-
Yoon KH, Hardy E, Han J
- KMID: 2368531
- Diabetes Metab J.
- 2017 Feb;41(1):69-74.
- doi: 10.4093/dmj.2017.41.1.69
BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clinical studies in patients with T2DM have shown that combining the glucagon-like peptide-1 receptor agonist... -
- CITED
-
- Close
- SHARE
-
- Close
- Low Plasma Insulin Level Prolonged Hypoglycemia after High dose Insulin Lispro Injection
-
Kang JH, Park HS
- KMID: 2368191
- J Korean Soc Clin Toxicol.
- 2016 Dec;14(2):151-154.
- doi: 10.22537/jksct.2016.14.2.151
Increased plasma insulin levels are often observed in exogenous insulin overdose patients. However, plasma insulin level may decrease with time. We report a case of low plasma insulin level hypoglycemia... -
- CITED
-
- Close
- SHARE
-
- Close
- The clinical analysis of hyperglycemic controls with four times daily administration of insulin on diabetes in pregnancy
-
Lee H, Kim SY, Lee JK, Lee ET, Jang JH, Lee JH, Park JH, Hwang SO, Song ES, Koh SK, Im MW, Lee WY
- KMID: 2272542
- Korean J Obstet Gynecol.
- 2005 Feb;48(2):391-400.
OBJECTIVE: To determine whether administrating insulin four times daily, compared to 1-3 times daily, improves maternal and perinatal outcomes of diabetes. METHODS: From August 1998 to April 2004, the 14... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Allergy to Insulin in Gestational Diabetes
-
Kim GJ, Kim SB, Jo SI, Shin JK, Kwon HS, Jeong H, Son JW, Lee SS, Kim SR, Kim BK, Yoo SJ
- KMID: 2407093
- Endocrinol Metab.
- 2015 Sep;30(3):402-407.
- doi: 10.3803/EnM.2015.30.3.402
Allergic reaction to insulin is uncommon since the introduction of human recombinant insulin preparations and is more rare in pregnant than non-pregnant females due to altered immune reaction during pregnancy.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Insulin Glargine in Adolescents with Uncontrolled type 1 Diabetes Mellitus
-
Lee YJ, Ko JM, Yoo HW
- KMID: 2321954
- J Korean Soc Pediatr Endocrinol.
- 2008 Jun;13(1):36-40.
PURPOSE: With long acting time of 24 hours and no peak concentration, insulin glargine (Lantus(R), Aventis Pharma, Frankfurt, Germany) is preferably used as basal insulin to control fasting glucose level.... -
- CITED
-
- Close
- SHARE
-
- Close
- Determining the Factors that Influence the Insulin Requirements in Type 2 Diabetic Patients
-
Chung JO, Cho DH, Chung DJ, Chung MY
- KMID: 2169016
- Endocrinol Metab.
- 2010 Jun;25(2):110-118.
- doi: 10.3803/EnM.2010.25.2.110
BACKGROUND: The initial insulin dose is often determined by clinical experience or with a formula using the body weight. However, it may be difficult to determine the initial insulin dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Therapeutic Efficacy of Different Oral Hypoglycemic Agents Combined with Once Daily Insulin Glargine in Type 2 Diabetic Subjects with Failure of Sulfonylurea and Metformin Combination
-
Hong SI, Kim HJ, Bae JM, Song SO, Park KS, Jeon BS, Hwang SD, Choi JY, Kim JH, Kwon HJ, Choi JS, Woo ML, Cho JH, Won YJ
- KMID: 2222521
- J Korean Diabetes Assoc.
- 2007 Jul;31(4):336-342.
- doi: 10.4093/jkda.2007.31.4.336
Backgroud: Although the extended duration of action of insulin glargine supports a convenient once daily injection, the combination with other short acting insulins or oral hypoglycemic agents is required to... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of Lantus on glycemic control in children and adolescents with type 1 diabetes mellitus
-
Rhie YJ, Chae HW, Kim HS, Kim DH
- KMID: 2278487
- Korean J Pediatr.
- 2007 Jun;50(6):565-569.
- doi: 10.3345/kjp.2007.50.6.565
PURPOSE: With a duration of action of approximately 24 hours and peakless levels, Lantus is a more physiologic basal insulin analogue compared with NPH. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
